Q3 SPARC deletion mutant and uses thereof

Details for Australian Patent Application No. 2006237613 (hide)

Owner Abraxis Bioscience, Inc.

Inventors Trieu, Vuong; Desai, Neil P.; SoonShiong, Patrick

Agent Pizzeys

Pub. Number AU-A-2006237613

PCT Pub. Number WO2006/112930

Priority 60/654,261 18.02.05 US

Filing date 17 February 2006

Wipo publication date 26 October 2006

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/39 (2006.01) Medicinal preparations containing peptides - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/112930 Priority application(s): WO2006/112930

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006237616-Antibodies and related molecules that bind to PSCA proteins

2006237611-Method of analyzing cell structures and their components